Total Payments
$6,869
2024 Payments
$2,220
Companies
47
Transactions
295
Medicare Patients
1,104
Medicare Billing
$130,077
Payment Breakdown by Category
Food & Beverage$6,843 (99.6%)
Education$26.16 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,843 | 294 | 99.6% |
| Education | $26.16 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,122 | 55 | $0 (2024) |
| Genentech USA, Inc. | $597.79 | 11 | $0 (2024) |
| UCB, Inc. | $466.52 | 17 | $0 (2024) |
| Biogen, Inc. | $409.40 | 13 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $304.91 | 9 | $0 (2021) |
| PFIZER INC. | $284.44 | 19 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $277.27 | 11 | $0 (2024) |
| SK Life Science, Inc. | $272.14 | 13 | $0 (2024) |
| Eisai Inc. | $265.53 | 10 | $0 (2024) |
| Lilly USA, LLC | $264.81 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,220 | 98 | ABBVIE INC. ($512.46) |
| 2023 | $1,365 | 57 | UCB, Inc. ($245.92) |
| 2022 | $1,120 | 63 | ABBVIE INC. ($285.29) |
| 2021 | $1,066 | 51 | Biohaven Pharmaceuticals, Inc. ($304.91) |
| 2020 | $319.77 | 12 | Lilly USA, LLC ($122.22) |
| 2019 | $593.02 | 11 | Genentech USA, Inc. ($247.70) |
| 2018 | $118.12 | 2 | Genentech USA, Inc. ($101.07) |
| 2017 | $66.82 | 1 | Genentech USA, Inc. ($66.82) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Neurology | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: PAIN | ||||||
| 12/13/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: PAIN | ||||||
| 11/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.41 | General |
| Category: Narcoplepsy | ||||||
| 11/12/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $4.43 | General |
| Category: Narcoplepsy | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Central Nervous System | ||||||
| 10/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: AMANTADINE | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: PAIN | ||||||
| 09/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: NEUROLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 469 | 547 | $166,692 | $55,943 |
| 2022 | 10 | 520 | 547 | $173,351 | $58,219 |
| 2021 | 4 | 115 | 120 | $45,042 | $15,915 |
Total Patients
1,104
Total Services
1,214
Medicare Billing
$130,077
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 113 | $28,058 | $13,047 | 46.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 80 | $39,055 | $10,280 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $22,899 | $7,043 | 30.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 48 | $8,755 | $4,484 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 57 | $13,217 | $4,324 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 39 | 39 | $14,307 | $3,854 | 26.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $8,514 | $2,717 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 24 | $6,822 | $2,601 | 38.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,982 | $2,180 | 36.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $7,377 | $1,973 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 25 | 26 | $6,087 | $1,521 | 25.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 16 | $2,048 | $997.12 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $3,571 | $921.57 | 25.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 76 | 76 | $36,444 | $11,526 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $24,390 | $7,995 | 32.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 67 | 67 | $26,096 | $7,954 | 30.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 56 | $14,696 | $7,268 | 49.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 46 | 46 | $20,376 | $6,537 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 57 | $12,850 | $4,244 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 24 | 24 | $8,606 | $2,364 | 27.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $6,462 | $2,195 | 34.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 35 | $4,235 | $1,936 | 45.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 17 | 18 | $5,204 | $1,826 | 35.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 22 | $3,778 | $1,673 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 28 | $4,659 | $1,317 | 28.3% |
About Dr. Sara Ramquist, DO
Dr. Sara Ramquist, DO is a Neurology healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1245762459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Ramquist, DO has received a total of $6,869 in payments from pharmaceutical and medical device companies, with $2,220 received in 2024. These payments were reported across 295 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($6,843).
As a Medicare-enrolled provider, Ramquist has provided services to 1,104 Medicare beneficiaries, totaling 1,214 services with total Medicare billing of $130,077. Data is available for 3 years (2021–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Dayton, OH
- Active Since 03/28/2017
- Last Updated 07/15/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1245762459
Products in Payments
- NURTEC ODT (Drug) $705.96
- QULIPTA (Drug) $525.39
- UBRELVY (Drug) $422.24
- Briviact (Drug) $362.79
- NUPLAZID (Drug) $260.14
- RYTARY (Drug) $240.34
- OCREVUS (Biological) $231.27
- VUMERITY (Drug) $208.92
- Leqembi (Drug) $170.61
- KESIMPTA (Drug) $162.68
- XYWAV (Drug) $156.44
- Aimovig (Biological) $143.24
- INBRIJA (Drug) $126.21
- EMGALITY (Drug) $116.50
- SOLIRIS (Biological) $114.22
- Exablate (Device) $102.69
- Gocovri (Drug) $100.88
- Fycompa (Drug) $94.92
- DUOPA (Drug) $93.81
- BOTOX (Biological) $93.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Dayton
Dr. Lawrence Goldstick, Md, MD
Neurology — Payments: $859,566
Neurology $859,566
Dr. Tracy Eicher, M.d, M.D
Neurology — Payments: $361,598
Neurology $361,598
Richard Kim, M.d, M.D
Neurology — Payments: $288,010
Neurology $288,010
Christopher Scheiner, Md, MD
Neurology — Payments: $208,270
Neurology $208,270
Joel Vandersluis, M.d, M.D
Neurology — Payments: $66,506
Neurology $66,506
Dr. Steven Arkin, M.d, M.D
Neurology — Payments: $39,074
Neurology $39,074